Robertson Sanford

Robertson Sanford serves as a Director at Cassava Sciences, Inc., a company focused on developing innovative therapies for neurodegenerative diseases. His recent disclosures, spanning from April 30, 2024, to May 16, 2024, include a total of 6 public filings. Notably, the largest reported move involved a grant/exercise valued at approximately $11.7 million, highlighting significant activity within the healthcare sector.